Aspen Pharmacare Holdings Limited (APNHY)
| Previous Close | 9.24 |
| Open | 9.24 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 9.24 - 9.24 |
| 52 Week Range | 7.43 - 10.88 |
| Volume | |
| Avg. Volume | 257 |
| Market Cap | 4.111B |
| Beta (5Y Monthly) | 0.74 |
| PE Ratio (TTM) | 13.59 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.18 (1.94%) |
| Ex-Dividend Date | Sept 21, 2023 |
| 1y Target Est | N/A |
- Simply Wall St.
Aspen Pharmacare Holdings Full Year 2023 Earnings: EPS Misses Expectations
Aspen Pharmacare Holdings ( JSE:APN ) Full Year 2023 Results Key Financial Results Revenue: R40.7b (up 5.4% from FY...
- Reuters
UPDATE 1-South African drugmaker Aspen posts 4% drop in annual profit
South African drugmaker Aspen Pharmacare on Wednesday posted a 4% drop in annual profit impacted by higher inflation and a drop in COVID-19 vaccine sales. For the year ended June 30, Aspen recorded headline earnings per share of 14.05 rand, down from 14.61 rand a year earlier. Aspen had bet big on a massive demand for COVID-19 vaccines emanating from Africa but as the panic around the pandemic waned it was left with a huge idle capacity, forcing it to scout for new partnerships for shoring up revenues and profits.
- Simply Wall St.
Owning 42% shares,institutional owners seem interested in Aspen Pharmacare Holdings Limited (JSE:APN),
Key Insights Given the large stake in the stock by institutions, Aspen Pharmacare Holdings' stock price might be...
